Houston, Texas 77030


Purpose:

This trial studies the problems that cancer patients face when filling prescriptions for opioids (medications that are used to manage pain). Pain is one of the most common symptoms among cancer patients. Opioid therapy is generally the treatment of choice for adequate management of cancer-related pain. Knowledge of these problems may help health care providers assess the most effective treatment options for cancer patients, and inform policy makers of the adjustments that need to be made to regulations to ensure cancer patients don't lose their access to opioids.


Study summary:

PRIMARY OBJECTIVES: I. To evaluate patients' perceptions of overall difficulties when filling their opioid prescription. SECONDARY OBJECTIVES: I. To determine cancer patients' perceptions of financial, logistical, and psychosocial difficulties when filling their opioid prescription. II. To evaluate the association between patient characteristics and patient difficulty filling opioid prescriptions. OUTLINE: Participants complete a survey over 5-10 minutes.


Criteria:

Inclusion Criteria: - Patients must be on opioids provided by the Supportive Care Center (SCC), and must have visited the SCC 2 previous times for the purpose of opioid pain management. This will ensure that 1) patients will have been told that they are being prescribed an opioid as a treatment for pain, and 2) patients will have gone to a pharmacy to fill their opioid prescription a minimum of one time. - Patients must be able to understand, read, write, and speak English. - Patients must sign an informed consent document. - Patients must have a cancer diagnosis. Exclusion Criteria: - Patients who have clinical evidence of cognitive impairment (Memorial Delirium Assessment Scale [MDAS] score of >= 13) as determined by the research staff, treating physician, or nurse. - Patients who are considered to be in severe physical or emotional distress based on the assessment by the research staff. - Patients who refuse to participate in the study.


NCT ID:

NCT03989128


Primary Contact:

Principal Investigator
Eduardo Bruera
M.D. Anderson Cancer Center

Eduardo Bruera
Phone: 713-792-6084
Email: ebruera@mdanderson.org


Backup Contact:

N/A


Location Contact:

Houston, Texas 77030
United States

Eduardo Bruera
Phone: 713-792-6082

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.